1. Discovery of new deafness genes through integration of basic research on gene expression in the inner ear with DNA sequence variants in patients with hearing loss and their families.
2. Molecular diagnosis of hereditary deafness throughout the lifespan from newborns through aging populations via comprehensive genetic analysis including high‐throughput genomic and transcript sequencing, copy number analyses, linkage analysis, genome‐wide association studies (GWAS), and appropriate genetic counseling.
3. Development of therapies for managing or treating hereditary hearing loss, including gene therapy strategies and genotype/phenotype correlations for determining prognosis.
4. Education of patients and their families about genetics of hearing and deafness, through written materials, lectures, and patient outreach activities.
5. Training of both clinicians (including ENT and Clinical Genetics residents) and auditory researchers (including postdoctoral fellows, graduate students, undergraduate students, and research interns) in molecular mechanisms, genetic diagnosis, and genotype‐guided targeted treatment for hearing loss.